These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 38517415)

  • 21. Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas.
    Zhang Q; Yang Y; You X; Ju Y; Zhang Q; Sun T; Liu W
    Front Oncol; 2023; 13():1173275. PubMed ID: 37546405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study.
    Machado I; Cruz J; Righi A; Gambarotti M; Ferrari C; Ruengwanichayakun P; Giner F; Rausell N; Lavernia J; Sugita S; Najera L; Suarez L; Sanjuan X; García JAN; García Del Muro FJ; Gómez-Mateo MC; Valladares MM; Ramos-Oliver I; Romagosa C; Parafioriti A; Elisabetta A; di Bernardo A; Navarro S; Hasegawa T; Arana E; Llombart-Bosch A
    Pathol Res Pract; 2021 Sep; 225():153562. PubMed ID: 34329836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Expression of Mucin-4 (MUC4) in Sarcomas Apart From Sclerosing Epithelioid Fibrosarcoma and Low-Grade Fibromyxoid Sarcoma.
    Hassan U; Saeed SM; Mushtaq S; Hussain M; Hameed M
    Cureus; 2023 Nov; 15(11):e49546. PubMed ID: 38156143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
    Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
    Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group.
    Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM
    Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience.
    Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D
    Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
    Jour G; Gullet A; Liu M; Hoch BL
    Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET.
    Benz MR; Dry SM; Eilber FC; Allen-Auerbach MS; Tap WD; Elashoff D; Phelps ME; Czernin J
    J Nucl Med; 2010 Aug; 51(8):1174-81. PubMed ID: 20660389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
    Tanriverdi O; Yildiz A
    J Oncol Pharm Pract; 2022 Apr; 28(3):635-645. PubMed ID: 35043739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas.
    Hasegawa T; Yamamoto S; Nojima T; Hirose T; Nikaido T; Yamashiro K; Matsuno Y
    Hum Pathol; 2002 Jan; 33(1):111-5. PubMed ID: 11823981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective audit of 957 consecutive
    Macpherson RE; Pratap S; Tyrrell H; Khonsari M; Wilson S; Gibbons M; Whitwell D; Giele H; Critchley P; Cogswell L; Trent S; Athanasou N; Bradley KM; Hassan AB
    Clin Sarcoma Res; 2018; 8():9. PubMed ID: 30116519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Contemporary Clinicopathologic Analysis of Primary Sarcomas of the Perinephric Soft Tissue and Hilar Vessels Including a Subset Secondarily Involving the Kidney.
    Scheiderer AN; Bahrami A; Master VA; Osunkoya AO
    Int J Surg Pathol; 2023 Oct; 31(7):1179-1186. PubMed ID: 36437683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
    ;
    Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical patterns of soft-tissue sarcoma in children].
    Méndez R; Arnáiz S; Montero M; Tellado M; País E; Ríos J; Vela D
    Cir Pediatr; 2001 Jan; 14(1):14-20. PubMed ID: 11339112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.